Effects of notch-1 down-regulation on malignant behaviors of breast cancer stem cells

Abstract

This study examined the effect of Notch-1 signaling on malignant behaviors of breast cancer cells by regulating breast cancer stem cells (BCSCs). BCSCs were enriched by using serum-free medium and knocked out of Notch-1 by using a lentiviral vector. Real-time polymerase chain reaction (RT-PCR) and Western blotting were used to detect the Notch-1 expression levels in breast cancer cell lines and BCSCs, and flow cytometry to detect the proportion of BCSCs in BCSC spheres. The BCSC self-renewal, migration, invasion, and tumorigenicity were examined by the tumor microsphere-forming assay and transwell assay and after xenotransplantation. The results showed that the Notch-1 silencing reduced the number of BCSC spheres, the proportion of BCSCs, and the number of cells penetrating through the transwell membrane. It also decreased the size of tumors that were implanted in the nude mice. These results suggest that Notch-1 signaling is intimately linked to the behaviors of BCSCs. Blocking Notch-1 signaling can inhibit the malignant behaviors of BCSCs, which may provide a promising therapeutical approach for breast cancer.

Keywords

Notch-1 / breast cancer / cancer stem cells / tumor metastasis / tumorigenesis

References

[1] ChenW, ZhengR, ZhangS, et al.. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res, 2013, 25(1): 10-21

[2] Al-HajjM, WichaMS, Benito-HernandezA, et al.. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988

[3] WangH, ChenNG, MinevBR, et al.. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. J Transl Med, 2012, 10: 167

[4] HassanKA, WangL, KorkayaH, et al.. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res, 2013, 19(8): 1972-1780

[5] GurselDB, BerryN, BoockvarJA. The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network. Neurosurgery, 2012, 70(2): N19-21

[6] MaD, DongX, ZangS, et al.. Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac J Clin Oncol, 2011, 7(4): 385-391

[7] GrudzienP, LoS, AlbainKS, et al.. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res, 2010, 30(10): 3853-3867

[8] DievartA, BeaulieuN, JolicoeurP. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene, 1999, 18(44): 5973-5981

[9] KlinakisA, SzabolcsM, PolitiK, et al.. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA, 2006, 103(24): 9262-9267

[10] CallahanR, EganSE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia, 2004, 9(2): 145-163

[11] HuC, DievartA, LupienM, et al.. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol, 2006, 168(3): 973-990

[12] ReedijkM, OdorcicS, ChangL, et al.. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res, 2005, 65(18): 8530-8537

[13] GallahanD, JhappanC, RobinsonG, et al.. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res, 1996, 56(8): 1775-1785

[14] ParrC, WatkinsG, JiangWG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med, 2004, 14(5): 779-786

[15] O’NeillCF, UrsS, CinelliC, et al.. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol, 2007, 171(3): 1023-1036

[16] RizzoP, MiaoH, D’SouzaG, et al.. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res, 2008, 68(13): 5226-5235

[17] Leth-LarsenR, TerpMG, ChristensenAG, et al.. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol Med, 2012, 18: 1109-1121

[18] DaveB, ChangJ. Treatment resistance in stem cells and breast cancer. J Mammary Gland Biol Neoplasia, 2009, 14(1): 79-82

[19] PhillipsTM, McBrideWH, PajonkF. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst, 2006, 98(24): 1777-1785

[20] FarnieG, ClarkeRB. Mammary stem cells and breast cancer—role of Notch signalling. Stem Cell Rev, 2007, 3(2): 169-175

[21] HarrisonH, FarnieG, HowellSJ, et al.. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res, 2010, 70(2): 709-718

[22] DontuG, JacksonKW, McNicholasE, et al.. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res, 2004, 6(6): R605-615

[23] LiuS, DontuG, MantleID, et al.. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res, 2006, 66(12): 6063-6071

[24] SimmonsMJ, SerraR, HermanceN, et al.. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro. Breast Cancer Res, 2012, 14(5): R126

[25] WangJ, FuL, GuF, et al.. Notch1 is involved in migration and invasion of human breast cancer cells. Oncol Rep, 2011, 26(5): 1295-1303